Back
BNP Paribas Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Buy
75
BNPQY
BNP Paribas
Last Price:
$41.61
Seasonality Move:
0.82%
Buy
63
RYTM
Rhythm Pharmaceuticals
Last Price:
$63.69
Seasonality Move:
15.42%
Buy
75
BNP Paribas (BNPQY)
is a Buy
Is BNP Paribas a Buy, Sell or Hold?
-
The current BNP Paribas [BNPQY] share price is $41.61. The Score for BNPQY is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
-
BNPQY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
63
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals [RYTM] share price is $63.76. The Score for RYTM is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BNPQY Stock Price Chart
What is BNP Paribas's stock price today?
-
The BNP Paribas share price today is $41.61Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BNPQY is experiencing buying pressure, which is a positive indicator for future bullish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $63.76Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.
BNPQY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.31 | Buy |
| Relative Strength Index (14 RSI): | 56.58 | Buy |
| Chaikin Money Flow: | 76887 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.35 - 42.89) | Buy |
| Bollinger Bands (100): | (31.11 - 40.51) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.28 | Buy |
| Relative Strength Index (14 RSI): | 63.66 | Buy |
| Chaikin Money Flow: | 369446 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.02 - 61.16) | Buy |
| Bollinger Bands (100): | (53.03 - 59.91) | Buy |
BNPQY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.8 | Buy |
| 20-day SMA: | 39.95 | Buy |
| 50-day SMA: | 39.99 | Buy |
| 200-day SMA: | 34.86 | Buy |
| 8-day EMA: | 40.82 | Buy |
| 20-day EMA: | 40.38 | Buy |
| 50-day EMA: | 39.29 | Buy |
| 200-day EMA: | 35.76 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 61.43 | Buy |
| 20-day SMA: | 57.42 | Buy |
| 50-day SMA: | 55.27 | Buy |
| 200-day SMA: | 53.46 | Buy |
| 8-day EMA: | 61.16 | Buy |
| 20-day EMA: | 58.64 | Buy |
| 50-day EMA: | 56.64 | Buy |
| 200-day EMA: | 52.62 | Buy |
BNP Paribas Earnings Growth & BNPQY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.17 per share, and a decrease next year of $0.00 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.26 per share, an increase next quarter of $0.07 per share, an increase this year of $1.54 per share, and an increase next year of $1.14 per share.
BNP Paribas Technical Analysis
| Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals Technical Analysis
| Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||